PMID- 25926140 OWN - NLM STAT- MEDLINE DCOM- 20160308 LR - 20150526 IS - 1745-7270 (Electronic) IS - 1672-9145 (Linking) VI - 47 IP - 6 DP - 2015 Jun TI - Poly(ADP-ribose) polymerase 1 inhibition prevents interleukin-1beta-induced inflammation in human osteoarthritic chondrocytes. PG - 422-30 LID - 10.1093/abbs/gmv033 [doi] AB - Osteoarthritis (OA) is an age-related joint disease that is characterized by the degeneration of articular chondrocytes. Nuclear enzyme poly(ADP-ribose) polymerase 1 (PARP-1) is associated with inflammation response. We investigated the role of PARP-1 in interleukin-1beta (IL-1beta)-stimulated human articular chondrocytes and its underlying mechanism. Cell viability and apoptosis were evaluated by using 3-(4,5)-dimethylthiahiazo(-z-y1)-3,5-di-phenytetrazoliumromide assay and flow cytometry, respectively. Tumor necrosis factor-alpha (TNF-alpha) level was measured by enzyme-linked immunosorbent assay. The mRNA and protein expression levels of PARP-1, IL-1 receptor (IL-1R), inducible nitric oxide synthase (iNOS), matrix metalloproteinases (MMPs), and tissue inhibitor of metalloproteinases-1 (TIMP-1) were determined by real-time reverse transcriptase-polymerase chain reaction and western blot analysis, respectively. The expression and phosphorylation of NF-small ka, CyrillicB p65 were measured by western blot analysis. Results showed that stimulation of chondrocytes with IL-1beta caused a significant up-regulation of PARP-1 and IL-1R, resulting in NF-small ka, CyrillicB p65 nuclear translocation and phosphorylation associated with an increase of TNF-alpha secretion and iNOS expression. PARP-1 was inhibited by siRNA transfection. Results showed that PARP-1 inhibition suppressed IL-1beta-induced reduction of cell viability and up-regulation of cell apoptosis, with a reduced IL-1R expression. PARP-1 inhibition also effectively reversed IL-1beta-induced inflammatory response through inhibiting the IL-1R/NF-small ka, CyrillicB pathway. These data suggested that PARP-1 inhibition prevents IL-1beta-induced inflammation response at least partly by inhibiting the IL-1R/NF-small ka, CyrillicB signaling pathway in human articular chondrocytes. Moreover, PARP-1 inhibition reduced MMPs expression and increased TIMP-1 expression, suggesting that PARP-1 inhibition could suppress cartilage destruction by modulating the balance between MMPs and TIMP-1. Inhibition of PARP-1 might be useful in the treatment of OA. CI - (c) The Author 2015. Published by ABBS Editorial Office in association with Oxford University Press on behalf of the Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences. FAU - Sun, Yujie AU - Sun Y AD - Orthopedics Department, Yantai Yuhuangding Hospital, Affiliated by Qingdao University Medical College, Yantai 264000, China. FAU - Zhou, Lugang AU - Zhou L AD - Orthopedics Department, Yantai Yuhuangding Hospital, Affiliated by Qingdao University Medical College, Yantai 264000, China. FAU - Lv, Dongmei AU - Lv D AD - Orthopedics Department, Yantai Yuhuangding Hospital, Affiliated by Qingdao University Medical College, Yantai 264000, China. FAU - Liu, Hongzhi AU - Liu H AD - Orthopedics Department, Yantai Yuhuangding Hospital, Affiliated by Qingdao University Medical College, Yantai 264000, China. FAU - He, Tian AU - He T AD - Orthopedics Department, Yantai Yuhuangding Hospital, Affiliated by Qingdao University Medical College, Yantai 264000, China. FAU - Wang, Xin AU - Wang X AD - Orthopedics Department, Yantai Yuhuangding Hospital, Affiliated by Qingdao University Medical College, Yantai 264000, China wangxinqd@sina.cn. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20150429 PL - China TA - Acta Biochim Biophys Sin (Shanghai) JT - Acta biochimica et biophysica Sinica JID - 101206716 RN - 0 (Interleukin-1beta) RN - 0 (NF-kappa B) RN - 0 (Poly(ADP-ribose) Polymerase Inhibitors) RN - EC 2.4.2.30 (Poly(ADP-ribose) Polymerases) SB - IM MH - Cells, Cultured MH - Chondrocytes/*pathology MH - Humans MH - Inflammation/*prevention & control MH - Interleukin-1beta/*physiology MH - NF-kappa B/metabolism MH - Osteoarthritis/pathology/*physiopathology MH - Poly(ADP-ribose) Polymerase Inhibitors/*pharmacology MH - Poly(ADP-ribose) Polymerases/*drug effects MH - Real-Time Polymerase Chain Reaction MH - Reverse Transcriptase Polymerase Chain Reaction OTO - NOTNLM OT - cartilage destruction OT - chondrocyte OT - inflammation response OT - interleukin-1beta OT - osteoarthritis OT - poly(ADP-ribose) polymerase 1 EDAT- 2015/05/01 06:00 MHDA- 2016/03/10 06:00 CRDT- 2015/05/01 06:00 PHST- 2014/12/12 00:00 [received] PHST- 2015/03/03 00:00 [accepted] PHST- 2015/05/01 06:00 [entrez] PHST- 2015/05/01 06:00 [pubmed] PHST- 2016/03/10 06:00 [medline] AID - gmv033 [pii] AID - 10.1093/abbs/gmv033 [doi] PST - ppublish SO - Acta Biochim Biophys Sin (Shanghai). 2015 Jun;47(6):422-30. doi: 10.1093/abbs/gmv033. Epub 2015 Apr 29.